Supportive Oligonucleotide Therapy (SOT) is a process that enables the lab to find the specific gene sequences of different targets such as cancer, Lyme, and various viruses and design a specific oligonucleotide therapy. The SOT is uniquely tailored to each patient’s needs. It is a small oligonucleotide which is complementary to a specific sequence of individual genes which are related to anti-apoptotic signals inside cancer cells, or genes essential for microorganisms and viruses’ survival or metabolism.
Apoptosis is another word for programmed cell death. In other words, the SOT molecule has a potent ability to block specific mRNA with an extremely high rate of specificity, therefore expression of desired gene is inhibited.